D-Wave's Government Windfall Meets a Reality Check: Revenue Slides, Insider Sales Mount, and a Nature Article Rattles the Sector

D-Wave stock slumps 47% from high as insiders sell $36M, even as U.S. executive orders mandate quantum adoption. Revenue plunged 81% but order intake surged 20x.

A crisp June morning brought two starkly different signals for D-Wave Quantum. The White House signed executive orders mandating a quantum migration across federal agencies, with D-Wave positioned as a prime candidate for the QC-ADDS program. Yet that same week, a paper in Nature by physicist Dr. Henry Legg tore into Microsoft’s topological quantum computing claims, sending a chill through the entire sector. The stock has been caught between a government lifeline and a cascade of operational and reputational headwinds.

The numbers tell a story of jarring contradiction. D-Wave reported first-quarter revenue of just $2.9 million, a staggering 81% plunge from a year earlier. But the company’s order intake surged to $33.4 million in the same period — nearly a twentyfold jump. Analysts have taken notice: the consensus loss-per-share estimate improved from $0.31 to $0.25. Yet the market remains unimpressed. The stock closed the week at €19.92, after trading recently around €20.27 — almost 47% below its 52-week high. Over the past 30 days, it has shed more than 21% of its value.

What the market appears to be watching more closely than the order book is the behavior of those inside the company. In the last six months, insiders have sold shares 22 times. Chief executive Alan Baratz cashed out roughly $18.95 million worth of stock, while CFO John Markovich liquidated nearly $17.23 million. Both executives disposed of large blocks precisely as the government was escalating its commitment to quantum technology — a timing that hardly signals confidence. Director Rohit Ghai also sold about 13,500 shares in mid-June, though that transaction was executed through a pre-arranged trading plan, and he retains more than 23,000 shares.

Institutional investors are voting with their feet as well. While 252 funds increased their positions, 302 reduced theirs, leaving net professional interest cooling. The annualized 30-day volatility sits at roughly 140%, making D-Wave one of the most turbulent names in the quantum space. Academic skirmishes add to the unease: beyond the Nature critique of Microsoft, D-Wave itself has had to defend its research against challenges from the Flatiron Institute. Such debates dampen the speculative fervor that quantum stocks once enjoyed.

On the bullish side, the government’s embrace is concrete. The two executive orders — 14412 and 14413, signed June 22, 2026 — oblige federal agencies to integrate quantum systems and specifically target Department of Energy facilities. D-Wave’s annealing technology is seen as the leading candidate for deployment. The DOE must deliver a strategy paper within 90 days of the order — by the end of September — spelling out procurement needs. If that document explicitly names D-Wave, the stock could rally toward its 50-day moving average of €20.23 and beyond. If it remains vague, the bearish pressure is likely to intensify.

Analyst targets reflect the split sentiment. The consensus price target stands at €32.31 on the German exchange, implying roughly 59% upside from current levels. A separate consensus in dollars calls for $36.84. Both numbers rest almost entirely on the assumption that government contracts will materialize quickly enough to offset the revenue collapse. The technical support level at €11.12, the 52-week low, offers a floor — but that floor will hold only if the autumn strategy paper delivers more than promises.

For now, D-Wave is a study in extremes: record bookings and a government mandate on one side, a revenue cliff and an insider exodus on the other. The next quarterly print will reveal whether the order surge is translating into billable revenue. Until then, the stock’s course depends on whether political will becomes a purchase order before the bears run out of patience.